Literature DB >> 16457019

Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?

Fabrizio Luppi1, Stefania Cerri, Luca Richeldi.   

Abstract

The idiopathic interstitial pneumonias (IIPs) comprise a number of clinico-pathological entities of unknown origin, which are sufficiently different from one another to be designated as separate disease entities. The aim of this review is to describe the level of evidence available on the efficacy of corticosteroids and immunosuppressive, antifibrotic, or immunomodulatory therapies in the treatment of different IIPs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16457019

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  2 in total

1.  Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.

Authors:  Amílcar S Damazo; André Lf Sampaio; Cintia Mag Nakata; Roderick J Flower; Mauro Perretti; Sonia M Oliani
Journal:  BMC Immunol       Date:  2011-10-19       Impact factor: 3.615

2.  Antisense oligonucleotide inhibition of heat shock protein (HSP) 47 improves bleomycin-induced pulmonary fibrosis in rats.

Authors:  Satoshi Hagiwara; Hideo Iwasaka; Shigekiyo Matsumoto; Takayuki Noguchi
Journal:  Respir Res       Date:  2007-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.